Here are the top Institutional holders of Oyster Point Pharma Inc. (OYST) shares

Oyster Point Pharma Inc. (NASDAQ: OYST) is 16.73% higher on its value in year-to-date trading and has touched a low of $13.26 and a high of $41.37 in the current 52-week trading range. The OYST stock was last observed hovering at around $28.45 in the last trading session, with the day’s gains setting it 0.08% off its average median price target of $60.00 for the next 12 months. It is also 56.11% off the consensus price target high of $65.00 offered by 3 analysts, but current levels are 50.81% higher than the price target low of $58.00 for the same period.

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .


Currently trading at $28.53, the stock is -4.21% and -5.60% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 59885.0 and changing 0.28% at the moment leaves the stock 2.69% off its SMA200. OYST registered a gain of 16.07% in past 6-months. The firm has a 50-day simple moving average (SMA 50) of $29.84 and a 200-day simple moving average (SMA200) of $30.24.

The stock witnessed a 0.25% loss in the last 1 month and extending the period to 3 months gives it a -20.51%, and is -9.49% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.54% over the week and 7.42% over the month.

Distance from 52-week low is 115.16% and -31.04% from its 52-week high.

Oyster Point Pharma Inc. (OYST) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Oyster Point Pharma Inc. (OYST) is a “Buy”. 3 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Oyster Point Pharma Inc. is expected to release its quarterly report on 09/02/2020 and quarterly earnings per share for the current quarter are estimated at -$0.8.The EPS is expected to shrink by -167.20% this year.

Oyster Point Pharma Inc. (OYST) Top Institutional Holders

67 institutions hold shares in Oyster Point Pharma Inc. (OYST), with 5.03M shares held by insiders accounting for 23.52% while institutional investors hold 115.16% of the company’s shares. The shares outstanding are 21.37M, and float is at 7.58M with Short Float at 5.21%. Institutions hold 88.08% of the Float.

The top institutional shareholder in the company is NEA Management Company, LLC with over 5.93 million shares valued at $207.39 million. The investor’s holdings represent 27.71% of the OYST Shares outstanding. As of Mar 30, 2020, the second largest holder is Invus Financial Advisors, LLC with 2.59 million shares valued at $90.65 million to account for 12.11% of the shares outstanding. The other top investors are Kohlberg Kravis Roberts & Co. L.P. which holds 1.04 million shares representing 4.86% and valued at over $36.39 million, while RTW Investments LP holds 4.53% of the shares totaling 0.97 million with a market value of $33.93 million.

Oyster Point Pharma Inc. (OYST) Insider Activity

A total of 8 insider transactions have happened at Oyster Point Pharma Inc. (OYST) in the last six months, with sales accounting for 0 and purchases happening 8 times.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free